Appraisal of treatment for severe sepsis in intensive care units.
Burchell
Monica
M
Ruiz
Francis
F
Barnett
David
D
D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use*; D003422:Critical Care / Q000191:economics*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic; D011486:Protein C / Q000191:economics / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy* / Q000191:economics
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated